Piramal Pharma Limited Cash Flow Reinvestment Rate
Piramal Pharma Limited cash flow reinvestment rate. Piramal Pharma Limited (PPLPHARMA) has a Cash Flow Reinvestment Rate of 0.49x as of September 2025, reinvesting Rs4.33 Billion (capex Rs4.33 Billion ) from operating cash flow of Rs8.90 Billion. See PPLPHARMA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Piramal Pharma Limited (2021–2026)
Cash flow reinvestment rate of Piramal Pharma Limited from 2021 to 2026. Historical reinvestment intensity for Piramal Pharma Limited across 6 annual periods. Explore how well can Piramal Pharma Limited service its debt to assess how comfortably operating cash covers total debt obligations.
Piramal Pharma Limited Cash Flow Reinvestment Rate by Year (2021–2026)
Piramal Pharma Limited cash flow reinvestment rate by year from 2021 to 2026. Year-by-year capital reinvestment analysis for Piramal Pharma Limited. For the full cash flow conversion analysis, see Piramal Pharma Limited (PPLPHARMA) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.64x | Rs8.95 Billion | Rs14.00 Billion | Rs8.90 Billion | ▼ -50.0% |
| 2025 | 1.28x | Rs11.42 Billion | Rs8.92 Billion | Rs6.64 Billion | ▲ +12.2% |
| 2024 | 1.14x | Rs11.46 Billion | Rs10.05 Billion | Rs7.12 Billion | ▼ -76.0% |
| 2023 | 4.76x | Rs23.04 Billion | Rs4.84 Billion | Rs9.65 Billion | ▼ -39.6% |
| 2022 | 7.89x | Rs20.13 Billion | Rs2.55 Billion | Rs2.01 Billion | ▼ -93.8% |
| 2021 | 127.91x | Rs44.41 Billion | Rs347.20 Million | Rs581.10 Million | — |